PRODUCTS
| Product Name | Strength | Image (not to scale) | Pack Size | NDC # | RLD / Brand Name | TE Rating | Therapeutic Category |
|---|---|---|---|---|---|---|---|
| Moxifloxacin Ophthalmic Solution USP | 0.5% |
 |
3mL in a 5mL bottle |
68180-421-01 |
Moxeza® |
AT2 |
Anti-infective |
| Formoterol Fumarate Inhalation Solution | 20mcg/2mL |
 |
30 UD Vials |
70748-261-30 |
Perforomist® |
AN |
Long-acting beta agonists (LABAs)/ Bronchodilator |
| Diclofenac Sodium Topical Solution | 2% |
|
112g |
68180-537-01 |
Pennsaid® 2% |
AB |
Topical nonsteroidal anti-inflammatory drug (NSAID) |
| Rufinamide Tablets USP | 200mg |
|
120 |
68180-803-16 |
Banzel® |
AB |
Anticonvulsants |
| Pentazocine and Naloxone Tablets USP | 50mg/0.5mg |
|
100 |
43386-680-01 |
Talwin® NX |
AB |
Adjunct to Anesthesia Opioid Analgesic |
| Lurasidone Hydrochloride Tablets | 20mg |
|
30 |
68180-673-06 |
Latuda® |
AB |
Atypical antipsychotics |
| Darunavir Tablets | 600mg |
|
30 |
68180-345-07 |
Prezista® |
AB |
Antiretrovirals |
| Turqoz™ | 0.3mg/0.03mg |
 |
28 x 3 |
68180-895-13 |
Lo/Ovral-28® |
AB |
Oral Contraceptives |
| Diazepam Rectal Gel | 10 mg & 20 mg |
|
4.4 cm & 6.0 cm |
43386-281-01 |
|||
| Bromfenac Ophthalmic Solution 0.07% | 0.07% |
 |
3mL |
68180-433-02 |
Prolensa® |
AT |
Nonsteroidal anti-inflammatory drugs (NSAIDs) |
| Varenicline Tartrate Tablets | 0.5mg |
|
53 |
70748-127-49 |
Chantix® |
AB |
Smoking Cessation Aids |
| Cyanocobalamin Nasal Spray | 500mcg/ spray |
|
4 UD |
43386-237-70 |
Nascobal® |
AB |
B12 Vitamins |
*All registered trademarks are the property of their respective owners. These products are intended for U.S. residents only.
